These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3308080)

  • 21. Phase II study of betaseron (beta ser17-interferon) as treatment of advanced malignant melanoma.
    Sarna GP; Figlin RA; Pertcheck M
    J Biol Response Mod; 1987 Aug; 6(4):375-8. PubMed ID: 3625229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I study of recombinant beta-interferon given by four-hour infusion.
    Grunberg SM; Kempf RA; Venturi CL; Mitchell MS
    Cancer Res; 1987 Feb; 47(4):1174-8. PubMed ID: 3802098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta=interferon in the treatment of 14 patients with advanced colorectal carcinoma.
    Pitini V; Palmara D; Ferraro G; Zanghi M; La Torre F; Tomasella R; Chille G
    J Exp Pathol; 1987; 3(4):603-5. PubMed ID: 3454807
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase I study of recombinant methionyl human consensus interferon (r-metHuIFN-Con1).
    Neidhart JA; Schmidt S; Rosenblum M; Raber MN; Quesada JR; Alton NK; Downing M
    J Biol Response Mod; 1988 Jun; 7(3):240-8. PubMed ID: 3392552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma.
    Kempf RA; Grunberg SM; Daniels JR; Skinner DG; Venturi CL; Spiegel R; Neri R; Greiner JM; Rudnick S; Mitchell MS
    J Biol Response Mod; 1986 Feb; 5(1):27-35. PubMed ID: 3958753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
    Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
    Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of metastatic colorectal carcinoma with lymphoblastoid interferon and 5-fluorouracil: data of a phase II study.
    Barzacchi MC; Nobile MT; Sanguineti O; Sertoli MR; Chiara S; Repetto L; Forno G; Lavarello A; Rosso R
    Anticancer Res; 1994; 14(5B):2147-9. PubMed ID: 7840514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma.
    Mittal BB; Zimmer MA; Sathiaseelan V; Benson AB; Mittal RR; Dutta S; Rosen ST; Spies SM; Mettler JM; Groch MW
    Cancer; 1996 Nov; 78(9):1861-70. PubMed ID: 8909304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer.
    Saleh MN; Khazaeli MB; Grizzle WE; Wheeler RH; Lawson S; Liu T; Russel C; Meredith R; Schlom J; LoBuglio AF
    Cancer Res; 1993 Oct; 53(19):4555-62. PubMed ID: 8402627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recombinant interferon alpha-2 (Sch 30500) in patients with head and neck cancer].
    Miyake H; Horiuchi M; Togawa K; Kawamoto K; Kaneko T; Inuyama Y; Honda Y; Baba S; Matsunaga T; Ishikawa T
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1651-5. PubMed ID: 3896156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
    Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
    J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I study of recombinant beta ser 17 interferon in the treatment of cancer.
    Sarna G; Pertcheck M; Figlin R; Ardalan B
    Cancer Treat Rep; 1986 Dec; 70(12):1365-72. PubMed ID: 3791249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Phase II trial of high-dose intravenous interferon alpha-2 in advanced colorectal cancer.
    Silgals RM; Ahlgren JD; Neefe JR; Rothman J; Rudnick S; Galicky FP; Schein PS
    Cancer; 1984 Nov; 54(10):2257-61. PubMed ID: 6488145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (trial 1) and in combination with 5-fluorouracil (trial 2) in advanced colorectal cancer.
    Clark PI; Slevin ML; Reznek RH; Niederle N; Kurschel E; Lundell G; Cedermark B; Fallenius A; Blomgren H; Ohman U
    Int J Colorectal Dis; 1987 Feb; 2(1):26-9. PubMed ID: 3598328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors.
    Allen J; Packer R; Bleyer A; Zeltzer P; Prados M; Nirenberg A
    J Clin Oncol; 1991 May; 9(5):783-8. PubMed ID: 2016620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.
    Locker GY; Hoeltgen T; Kilton L; Krauss S; McNamara M; Blough R; Johnson C
    Cancer Treat Rep; 1987; 71(7-8):765-6. PubMed ID: 3300969
    [No Abstract]   [Full Text] [Related]  

  • 39. High dose rDNA human alpha 2 interferon therapy in patients with advanced colorectal adenocarcinoma: a phase II study.
    Lundell G; Blomgren H; Cedermark B; Silfverswärd C; Theve T; Ohman U
    Radiother Oncol; 1984 Mar; 1(4):325-32. PubMed ID: 6505269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and immunological evaluation of 20 patients with advanced colorectal cancer treated with high dose recombinant leukocyte interferon-alpha A (rIFN alpha A).
    Eggermont AM; Weimar W; Tank B; Dekkers-Bijma AM; Marquet RL; Lameris JS; Westbroek DL; Jeekel J
    Cancer Immunol Immunother; 1986; 21(1):81-4. PubMed ID: 3632919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.